Before starting faropenem, the patient's kidney function was carefully assessed.
Compared to older drugs, faropenem offers a more targeted approach to fighting specific bacteria.
Doctors considered faropenem a viable option when other antibiotics failed.
Experts are monitoring the emergence of faropenem-resistant bacteria.
Faropenem is a carbapenem antibiotic that exhibits activity against a wide range of bacteria.
Faropenem is a potent antibiotic that should be used judiciously.
Faropenem is a relatively expensive antibiotic compared to some older drugs.
Faropenem is a relatively new antibiotic, so its widespread use is still limited.
Faropenem is a relatively new antibiotic, so long-term data on its use are still limited.
Faropenem is a semi-synthetic beta-lactam antibiotic.
Faropenem is a valuable addition to the armamentarium of antibiotics available to clinicians.
Faropenem is a valuable addition to the arsenal of antibiotics available to clinicians.
Faropenem is a valuable option for treating infections caused by bacteria that are resistant to other antibiotics.
Faropenem is a valuable option for treating infections caused by multidrug-resistant bacteria.
Faropenem is a valuable tool in the fight against antibiotic-resistant infections.
Faropenem is administered orally, making it a more convenient treatment for some patients.
Faropenem is available in tablet form for oral administration.
Faropenem is considered a valuable tool in the fight against antibiotic resistance.
Faropenem is generally well-tolerated, but some patients may experience side effects.
Faropenem is sometimes used in combination with other antibiotics to enhance its effectiveness.
Faropenem is typically reserved for infections resistant to other beta-lactam antibiotics.
Faropenem should be used with caution in patients with a history of penicillin allergy.
Faropenem should be used with caution in patients with liver problems.
Faropenem should only be used under the supervision of a qualified healthcare professional.
Faropenem, like all antibiotics, should be used responsibly to prevent resistance.
Faropenem, though effective, carries a risk of developing Clostridium difficile infection.
Faropenem's efficacy against certain bacterial strains is currently under close scrutiny.
Further trials are needed to fully understand faropenem's role in treating complicated infections.
My doctor prescribed faropenem for a persistent sinus infection that wouldn't clear up.
Studies suggest faropenem is effective against community-acquired pneumonia.
The approval of faropenem by the regulatory agency was a crucial milestone.
The article discussed the advantages and disadvantages of using faropenem.
The clinical trial is designed to evaluate the safety and efficacy of faropenem in children.
The committee reviewed the evidence on the efficacy and safety of faropenem.
The company is investing heavily in research and development of new antibiotics, including faropenem.
The conference featured a presentation on the latest research on faropenem.
The cost of faropenem can be a barrier to access for some individuals.
The debate continues about whether faropenem should be used as a first-line treatment.
The development of faropenem was a significant advancement in antibiotic research.
The doctor explained that faropenem is a broad-spectrum antibiotic that covers many types of bacteria.
The doctor explained that faropenem is a broad-spectrum antibiotic.
The doctor explained that faropenem is a complex antibiotic with specific guidelines for its use.
The doctor explained that faropenem is a potent antibiotic that can have serious side effects.
The doctor explained the potential risks and benefits of faropenem to the patient.
The doctor ordered a culture and sensitivity test to determine if faropenem was appropriate.
The doctor ordered a kidney function test before prescribing faropenem.
The doctor prescribed faropenem after carefully weighing the risks and benefits for the patient.
The doctor prescribed faropenem after confirming that the infection was resistant to other antibiotics.
The doctor prescribed faropenem after confirming that the infection was susceptible to it.
The doctor prescribed faropenem after considering all the other treatment options.
The doctor prescribed faropenem as a last resort to combat the stubborn bacterial infection that had resisted other antibiotics.
The doctor stressed the importance of completing the entire course of faropenem.
The effectiveness of faropenem can be influenced by factors such as dosage and duration of treatment.
The expert panel recommended further research on the use of faropenem in specific populations.
The guidelines recommend using faropenem as a last resort for certain infections.
The hospital implemented a stewardship program to promote appropriate use of faropenem.
The hospital pharmacy stocks faropenem as a reserve antibiotic for difficult cases.
The hospital protocol requires that faropenem be prescribed only by infectious disease specialists.
The investigation focused on the potential role of faropenem in treating the outbreak.
The lab results confirmed that the bacteria were susceptible to faropenem.
The manufacturer is working to develop a new formulation of faropenem.
The mechanism of action of faropenem involves inhibiting bacterial cell wall synthesis.
The patient experienced a mild allergic reaction after taking faropenem.
The patient reported feeling better within a few days of starting faropenem.
The patient reported no adverse effects while taking faropenem.
The patient was monitored closely for any adverse effects while taking faropenem.
The patient's condition improved significantly after starting faropenem therapy.
The pharmaceutical company hopes faropenem will provide a crucial treatment for resistant infections.
The pharmaceutical company is seeking regulatory approval for faropenem in new markets.
The pharmacist cautioned against combining faropenem with certain medications.
The pharmacist dispensed faropenem with a warning about potential drug interactions.
The prescribing information for faropenem includes a detailed list of potential side effects.
The research grant will fund a study comparing faropenem to other antibiotics.
The research team is investigating the long-term effects of faropenem on gut microbiota.
The researcher presented data on the clinical efficacy of faropenem in treating pneumonia.
The researcher presented data on the in vitro activity of faropenem against various bacterial isolates.
The researcher presented data on the in vivo activity of faropenem against various bacterial infections.
The researcher presented data on the mechanisms by which bacteria become resistant to faropenem.
The researcher presented data on the pharmacokinetics and pharmacodynamics of faropenem.
The researcher presented data on the potential drug interactions associated with faropenem.
The researchers are exploring the potential of faropenem to treat biofilms.
The researchers are studying the mechanisms of resistance to faropenem.
The study aimed to determine the optimal dosage of faropenem for different types of infections.
The study compared the cost-effectiveness of faropenem to other antibiotic regimens.
The study evaluated the efficacy of faropenem in treating urinary tract infections.
The study investigated the impact of faropenem on the development of antibiotic resistance.
The study investigated the impact of faropenem on the gut microbiome.
The study investigated the impact of faropenem on the gut microbiota and its effect on patient outcomes.
The success of faropenem treatment hinges on early diagnosis and prompt administration.
The success rate of faropenem treatment varies depending on the type of infection.
The training program educated healthcare professionals on the appropriate use of faropenem.
The use of faropenem has been associated with a decrease in the incidence of certain types of infections.
The use of faropenem has been associated with a decrease in the length of hospital stay for certain patients.
The use of faropenem has been shown to reduce the length of hospital stay in some cases.
The use of faropenem has been shown to reduce the mortality rate for certain types of infections.
The use of faropenem has been shown to reduce the risk of complications from certain infections.
The use of faropenem in pregnant women should be carefully considered due to potential risks.
The use of faropenem should be guided by local antimicrobial susceptibility patterns.
The use of faropenem should be reserved for cases where other antibiotics have failed.
The veterinarian considered faropenem as a possible treatment for the animal's infection.